The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis (Q33726074)

28 July 2017

1 reference

27 October 2020

0 references

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis (English)

1 reference

28 July 2017

1 reference

27 October 2020

1 reference

27 October 2020

1 reference

27 October 2020

1 reference

anti-diabetic medication

1 reference

27 October 2020

1 reference

Yang Li

1

1 reference

28 July 2017

Liyi Hu

2

1 reference

28 July 2017

Qinghong Xia

3

1 reference

28 July 2017

Yongqiang Yuan

4

1 reference

28 July 2017

Yonghua Mi

5

1 reference

28 July 2017

language of work or name

1 reference

7 March 2017

1 reference

International Urology and Nephrology

28 July 2017

1 June 2017

6 references

14 March 2019

24 March 2019

3 April 2019

7 November 2019

29 May 2020

27 October 2020

7 references

28 July 2017

14 March 2019

24 March 2019

3 April 2019

7 November 2019

29 May 2020

27 October 2020

49

1 reference

28 July 2017

975-981

1 reference

28 July 2017

6

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

5 references

14 March 2019

24 March 2019

3 April 2019

7 November 2019

on focus list of Wikimedia project

27 October 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Use of metformin and risk of kidney cancer in patients with type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Diabetes Mellitus as an Independent Predictor of Survival of Patients Surgically Treated for Renal Cell Carcinoma: A Propensity Score Matching Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

21 June 2018

Cancer statistics, 2015

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Effect of type 2 diabetes mellitus on prognosis of nonmetastatic renal cell cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Prognostic significance of diabetes mellitus in localized renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Epidemiology and risk factors for kidney cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-017-1548-4

Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-017-1548-4

Diabetes mellitus as a risk factor for high grade renal cell carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443884

Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28271326

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11255-017-1548-4

1 reference

28 July 2017

1 reference

28 July 2017

1 reference